| A Cell Wall–Degrading Esterase of Xanthomonas oryzae Requires a Unique Substrate Recognition Module for Pathogenesis on Rice G Aparna, A Chatterjee, RV Sonti, R Sankaranarayanan The Plant Cell 21 (6), 1860-1873, 2009 | 85 | 2009 |
| Advances in targeting the WNT/β-catenin signaling pathway in cancer A Chatterjee, S Paul, B Bisht, S Bhattacharya, S Sivasubramaniam, ... Drug Discovery Today 27 (1), 82-101, 2022 | 69 | 2022 |
| Structural insights into the regulation of cohesion establishment by Wpl1 A Chatterjee, S Zakian, XW Hu, MR Singleton The EMBO journal 32 (5), 677-687, 2013 | 52 | 2013 |
| Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis Y Yan, B Zhou, C Qian, A Vasquez, M Kamra, A Chatterjee, YJ Lee, ... Nature Communications 13 (1), 669, 2022 | 27 | 2022 |
| Neuropilin 1 regulates bone marrow vascular regeneration and hematopoietic reconstitution CM Termini, A Pang, T Fang, M Roos, VY Chang, Y Zhang, NJ Setiawan, ... Nature Communications 12 (1), 6990, 2021 | 18 | 2021 |
| Crystallization and preliminary crystallographic studies of LipA, a secretory lipase/esterase from Xanthomonas oryzae pv. oryzae G Aparna, A Chatterjee, G Jha, RV Sonti, R Sankaranarayanan Acta Crystallographica Section F: Structural Biology and Crystallization …, 2007 | 13 | 2007 |
| Disabling the nuclear translocalization of RelA/NF-κB by a small molecule inhibits triple-negative breast cancer growth H Kanzaki, A Chatterjee, H Hossein Nejad Ariani, X Zhang, S Chung, ... Breast Cancer: Targets and Therapy, 419-430, 2021 | 10 | 2021 |
| Functional divergence of a bacterial enzyme promotes healthy or acneic skin IA Hajam, M Katiki, R McNally, M Lázaro-Díez, S Kolar, A Chatterjee, ... Nature Communications 14 (1), 8061, 2023 | 4 | 2023 |
| RIPK2 stabilizes c-Myc and is an actionable target for inhibiting prostate cancer metastasis Y Yan, B Zhou, C Qian, A Vasquez, A Chatterjee, X Yuan, E Posadas, ... bioRxiv, 2020.05. 14.096867, 2020 | 2 | 2020 |
| Profiling phagosome proteins identifies PD-L1 as a fungal-binding receptor K Li, A Chatterjee, C Qian, K Lagree, Y Wang, CA Becker, MR Freeman, ... Nature, 1-8, 2024 | 1 | 2024 |
| The homeodomain drives favorable DNA binding energetics of prostate cancer target ONECUT2 A Chatterjee, B Gallent, M Katiki, C Qian, MR Harter, MR Freeman, ... bioRxiv, 2023.06. 13.544830, 2023 | 1 | 2023 |
| Marine Biotherapeutics: Delving Into The Vast Untapped Resource Of Therapeutic Molecules Showing Better Outcomes Against Diseases M Trivedi, P Vasani, A Sonowal, R Mukherjee, A Chatterjee, D Banerjee Educational Administration: Theory and Practice 30 (6 (S)), 01-07, 2024 | | 2024 |
| Inhibitory Effect Of Natural Extracts Against Bacteriophages Towards Evaluation Of Their Anti-Viral Potential S Bhaglani, A Chatterjee, R Mukherjee, D Banerjee Educational Administration: Theory and Practice 30 (6 (S)), 38-43, 2024 | | 2024 |
| 296 Towards Nose-to-brain Inhibition of NFB: Activity of a Novel p65 Inhibitor in Glioblastoma and Feasibility of Intranasal Delivery With a Near-infrared Fluorescent HMC … MET Lavieri, M Michel, S Mohyeddinipour, L Israel, H Wang, K Miyaguchi, ... Neurosurgery 70 (Supplement_1), 85, 2024 | | 2024 |
| DNA binding mechanism of prostate cancer target ONECUT2 A Chatterjee, B Gallent, M Katiki, C Qian, MR Harter, MR Freeman, ... Cancer Research 84 (6_Supplement), 5767-5767, 2024 | | 2024 |
| Abstract B064: ONECUT2 inhibition, a potential treatment for lethal prostate cancer B Gallent, C Qian, A Chatterjee, M Katiki, R Murali, MR Freeman Cancer Research 83 (11_Supplement), B064-B064, 2023 | | 2023 |
| Incorporation of unnatural amino acids into the capsid of adeno-associated virus RE Kelemen, R Mukherjee, X Cao, SB Erickson, Y Zheng, A Chatterjee New tools at the intersection of genetic code expansion, virus engineering …, 2019 | | 2019 |
| Structural and biochemical studies of cohesin regulation by Wpl1 A Chatterjee Cancer Research UK - London Research Institute, 2013 | | 2013 |
